Bioniche
February 12, 2008 Bioniche Reports Fiscal 2008 Second Quarter February 8, 2008 Bioniche Receives $5 Million Capital Financing Support to Scale-up E. News Release Bioniche Life Sciences signs agreement with US pharmaceutical company 26/02/02 BELLEVILLE, ON, February 26, 2002 a Bioniche Life Sciences Inc., (BNC: TSE), a fully integrated Canadian biopharmaceutical company...
Bioniche
February 12, 2008 Bioniche Reports Fiscal 2008 Second Quarter February 8, 2008 Bioniche Receives $5 Million Capital Financing Support to Scale-up E. The net loss of $4.96 million or ($0.18) per share for the 12 months ending June 30th, 2002 compares to a loss of $3.1 million or ($0.13) per share for the fiscal year ended June 30th, 2001. This growth compares favourably to an...
Clinical Pharmacology
Prescribing Kevin Clinical Pharmacology Isla Mackenzie _ _ Clinical Pharmacology Prescribing October 2005 Dr Joseph Cheriyan Dr Fraz Mir Why use drugs? Will the drug chosen will bring this about? * Safety & tolerability * Efficacy Cost-effectiveness Why take a drug history? alcohol and other medicines The prescription pitfalls Doses * * * Route Choose an...
author: Isla Mackenzie
duplicates:http://www-clinpharm.medschl.cam.ac.uk/pages/teaching/documents/PrescribingLectureSlides2005.ppt http://www-clinpharm.medschl.cam.ac.uk/pages/teaching/course/documents/PrescribingLectureSlides2005.ppt
Acetaminophen Poisoning: Poisoning: Merck Manual Home Edition
Section Accidents and Injuries Subject Poisoning Acetaminophen Poisoning More than 100 products contain acetaminophen , a common over-the-counter pain reliever (see Over-the-Counter Drugs: Acetaminophen ). If several similar products are consumed at a time, a person may inadvertently take too much acetaminophen. Acetaminophen usually is a very safe drug, but it is not harmless....
Acetaminophen Poisoning: Poisoning: Merck Manual Home Edition
Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
THE MERCK MANUAL, Sec. 6, Ch. 63, Approach To The Pulmonary Patient
This Publication Is Searchable The Merck Manual of Diagnosis and Therapy--- Section 6. A cough can be distressing when it appears suddenly, especially if associated with discomfort due to chest pain, dyspnea, or copious secre tions. A cough that is associated with rhinitis or wheezing or that is seasonal may be an allergic response. The presence of squamous cells suggests...
THE MERCK MANUAL, Sec. 4, Ch. 43, Drugs And The Liver
This Publication Is Searchable The Merck Manual of Diagnosis and Therapy--- Section 4. Other drugs produce damage only rarely in susceptible persons; the injury is generally unpredictable and not dose-related. Mild jaundice can occur from drug-induced hemolysis with unconjugated hyperbilirubinemia, but no true hepatic damage occurs and liver function tests are normal. ...
THE MERCK MANUAL, Sec. 19, Ch. 263, Injuries, Poisoning, And Cardiopulmonary Resuscitation
This Publication Is Searchable The Merck Manual of Diagnosis and Therapy--- Section 19. Symptoms are usually mild until >= 48 h postingestion and can be described in four stages, as shown in Table 263-3.Acetylcysteine is available as a 20% solution (200 mg/mL) in vials of 4, 10, 30, and 100 mL and should be diluted 1:4 in a carbonated beverage or fruit juice before...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, MACRODANTIN to NYTOL
Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS MACRODANTIN to NYTOL Trade Name Generic MACRODANTIN Nitrofurantoin MANDELAMINE Methenamine MANDOL Cefamandole MAREZINE Cyclizine MARINOL Dronabinol MATULANE Procarbazine MAVIK Trandolapril MAXALT Rizatriptan MAXAQUIN Lomefloxacin MAZANOR Mazindol MECLOMEN Meclofenamate MEDROL Methylprednisolone...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Abciximab to Butorphanol
Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Abciximab to Butorphanol Generic Trade Name Abciximab REOPRO Acarbose PRECOSE Acebutolol SECTRAL Acetaminophen TYLENOL Acetazolamide DIAMOX Acetohexamide DYMELOR Acetohydroxamic acid LITHOSTAT Acetophenazine TINDAL Acetylcysteine MUCOMYST ACTH See Corticotropin Acyclovir ZOVIRAX Adenosine...
Mucolytics for cystic fibrosis - [Medication] - Quest Diagnostics Patient Health Library
Mucolytics for cystic fibrosis Examples Brand Name Chemical Name Mucomyst acetylcysteine How It Works Mucolytics dissolve mucus in the lungs or intestines, making the mucus thinner and less sticky. Nausea Throwing up Fever Runny nose Drowsiness Clammy skin See Drug Reference for a full list of side effects.Acetylcysteine irritates the lungs and causes more coughing.
Mucolytics for chronic obstructive pulmonary disease (COPD) - [Medication] - Quest Diagnostics Patient Health Library
Mucolytics for chronic obstructive pulmonary disease (COPD) Examples Brand Name Chemical Name Mucomyst, Mucosil-10, Mucosil-20 acetylcysteine Organidin, Iophen, Par Glycerol, R-Gen iodinated glycerol How It Works Mucolytics thin mucus to make it less sticky and easier to cough up from the lungs and airways leading to the lungs ( bronchial tubes ). Topic Contents - Examples - How...
Publications
Home --- | --- Projects ---| --- Funding --- | --- Faculty & Staff --- | --- Publications --- | --- Links --- | --- Contact Us Publications Read Entire Texts Online To Err is Human: Building A Safer Health System - Read the Institute of Medicine report online. 2005 Feb 14;165(3):333-7 Nallomathu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER.- Is ...
ProductCatalog
Pr o d u c t s 2 0 0 3/ 2004 PHARMA GROUP LIMITED Bioniche Life Sciences Inc. CORPORATE PROFILE PHARMA GROUP LIMITED CONTENTS Acetylcysteine (Parvolex®)_ _ _ _ _ 2 Amiodarone _ _ _ _ _ _ _ _ _ _ _ 2 Ascorbic Acid _ _ _ _ _ _ _ _ _ _ _ 2 Ascorbic Acid (BetaC®) _ _ _ _ _ _ 2 B- Complex 100 Injection _ _ _ _ _ _ 3 Bacteriostatic Sodium Chloride _ _ _ 3 Carbachol Tablets _ _...
author: Kathy Vandermey
duplicates:http://www.bioniche.com/pdf/ProductCatalog.pdf
ProductCatalog page 4
author: Kathy Vandermey
duplicates:http://www.bioniche.com/pdf/ProductCatalog.pdf
ProductCatalog page 3
author: Kathy Vandermey
duplicates:http://www.bioniche.com/pdf/ProductCatalog.pdf
BiositeA® Inc. Web Site -- Investor & Media Relations -- News
Deutsch English Espanol Francais Italiano ---- OVERVIEW PRODUCTS ENCOMPASS ™ SUPPORT INVESTORS INTERNATIONAL DISCOVERY HOME OVERVIEW COMPANY NEWS STOCK INFORMATION FINANCIAL INFORMATION INVESTOR CENTER INFORMATION REQUEST CORPORATE INFORMATION Biosite(R) Announces FDA Clearance to Market Triage(R) TOX Drug Screens With Acetaminophen - New Analyte Broadens Testing Spectrum for...
http://www.adherex.com/pdf/AdherexQ3Mar04.pdf
Quarterly Report Quarterly Report Financial Statements for the Third Quarter Ended March 31, 2004 Q3 In the third quarter, Adherex continued its evolution to an enterprise focusing on the development of important and innovative approaches to the treatment of cancer Also in December 2003, the Company made a 50 percent investment in 2037357 Ontario Inc., an Ontario corporation,...
Adherex Technologies Inc.
- Adherex A nnounces Merger with Oxiquant N ew entity will focus on developing pipeline of anti-cancer compounds - OTTAWA, ONTARIO, October 2, 2002 Adherex Technologies Inc The four compounds include Exherin, Adherexs drug candidate that targets N-cadherin to destroy cancer blood vessels, and three products from Oxiquant: Sodium Thiosulfate (STS), a...
Adherex Technologies Inc.
- Adherex - Oxiquant Merger Completed Company has four anti-cancer compounds ready for clinical development- Ottawa, ON (November 21, 2002) Adherex Technologies (TSX: AHX), a drug discovery and development company with an exclusive focus on cancer, today announced its merger with Oxiquant Inc Oxiquant has three products currently in the clinical stage of development: Sodium...
Adherex Technologies Inc.
- New CEO Announced for Adherex World-renowned oncologist and breast cancer specialist to lead oncology company OTTAWA, ONTARIO, February 19, 2003 Adherex Technologies Inc As Adherex becomes specialized in cancer treatments, I felt it was important to have someone who is totally immersed in the field lead the Company through to commercialization and Bill is certainly...
http://www.adis.com/files/newsletters/REA/Rxcov998.pdf
20 Cyclophosphamide/ doxorubicin/ prednisone/ vincristine: 10 Pharmacovigilance & Regulatory News leukaemia cutis [ ] Antipsychotic manufacturers update labelling following FDA 2 Dexamethasone: psychosis [S] 11 request Diphenhydramine: interaction with concomitant linezolid 11 Carvedilol- associated diarrhoea: reports from NZ CARM 3 leading to delirium [ X S] Ephedrine- containing...
http://www.adis.com/files/newsletters/REA/Rxcov992.pdf
16 - acetyldigoxin: interaction with concomitant amiodarone and 6 Current Issues & Opinions bisoprolol leading to torsade de pointes [ X S] The Lancet publishes retraction of autism study's interpretation 2 Bisoprolol: interaction with concomitant amiodarone and - 6 Pharmacovigilance & Regulatory News acetyldigoxin leading to torsade de points [ X S] Estrogen- alone WHI study stopped...
Prescription and Over-the-Counter Drug Product List: 1/2004
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETYLCYSTEINE >A> INJECTABLE; INTRAVENOUS >A> ACETADOTE >A> + CUMBERLAND PHARMS 6GM /30ML(200MG/ML) N21539 001 JAN 23, 2004 JAN NEWA ALBUTEROL SULFATE TABLET, EXTENDED RELEASE; ORAL ALBUTEROL SULFATE >D> AB PLIVA EQ 4MG BASE N76130 002 SEP 26, 2002 JAN CRLD >A> + EQ 4MG BASE N76130 002 SEP 26, 2002 JAN CRLD >D> AB EQ 8MG...
NDA Approvals for Calendar Year 2004
FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -NDA Approvals for Calendar Year 2004 Updated through January 31, 2004 NDA NUMBER DRUG NAME GENERIC NAME APPLICANT/ SPONSOR CHEMICAL TYPE THERAPEUTIC CLASS APPROVAL DATE 21604 Children's Elixsure IB Ibuprofen Taro Pharms 5 S 07-Jan-04 21539 Acetadote Acetylcysteine Cumberland Pharms 3...